However, doctors often prescribe it off-label to help with weight loss
While the FDA doesn't approve cosmetic ingredients, topical GHK-Cu peptide is generally considered safe and is available in over-the-counter products
In certain regions, public health plans may subsidize a portion of the cost, but in others, individuals frequently bear the expense themselves
New GLP-1 receptor agonist formulations, such as once-weekly injectable and oral versions, are gaining traction, improving patient compliance and market reach
Despite this potential, given the known long-term benefit of lowering hemoglobin A1c in preventing DR progression, there does not appear to be any contraindication to initiating GLP-1/GIP agonist therapy with appropriate ocular monitoring
Exp Mol Med 52 , 11981208 (2020)